Condition: Deep Venous Thrombosis · Sponsor: Yale University
The goal of the CRETE Studies is to investigate the newly identified age-dependent heterogeneity in the efficacy of enoxaparin in reducing the risk of central venous catheter-associated deep venous thrombosis in critically ill children.
This description comes directly from the study's public registry record.
E. Vincent Faustino, MD, MHS · 203-785-4651 · vince.faustino@yale.edu
Tara McPartland, MSW, MPH · 203-737-7173 · tara.mcpartland@yale.edu
Always discuss trial participation with your own doctor first.
| Children's of Alabama | Birmingham, Alabama, United States | Recruiting |
| Arkansas Children's Hospital | Little Rock, Arkansas, United States | Recruiting |
| Children's Hospital Colorado | Aurora, Colorado, United States | Recruiting |
| Yale-New Haven Children's Hospital | New Haven, Connecticut, United States | Recruiting |
| University of Florida -UF Health | Gainesville, Florida, United States | Recruiting |
| Johns Hopkins All Children's | St. Petersburg, Florida, United States | Recruiting |
| Children's Hospital of Illinois at OSF Saint Francis Medical Center | Peoria, Illinois, United States | Recruiting |
| Stead Family Children's Hospital | Iowa City, Iowa, United States | Recruiting |
| Children's Hospital St. Louis | St Louis, Missouri, United States | Recruiting |
| Hassenfeld Children's Hospital | New York, New York, United States | Recruiting |
| New York Presbyterian Hospital | New York, New York, United States | Recruiting |
| Golisano Children's Hospital | Rochester, New York, United States | Recruiting |
+ 10 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04924322